Reduced CSF CART in dementia with Lewy bodies
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Reduced CSF CART in dementia with Lewy bodies. / Schultz, Kristofer; Wiehager, Sara; Nilsson, Karin; Nielsen, Jørgen E; Lindquist, Suzanne G; Hjermind, Lena E; Andersen, Birgitte B; Wallin, Anders; Nilsson, Christer; Petersén, Asa.
I: Neuroscience Letters, Bind 453, Nr. 2, 2009, s. 104-6.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Reduced CSF CART in dementia with Lewy bodies
AU - Schultz, Kristofer
AU - Wiehager, Sara
AU - Nilsson, Karin
AU - Nielsen, Jørgen E
AU - Lindquist, Suzanne G
AU - Hjermind, Lena E
AU - Andersen, Birgitte B
AU - Wallin, Anders
AU - Nilsson, Christer
AU - Petersén, Asa
N1 - Keywords: Aged; Alzheimer Disease; Amyloid beta-Protein; Analysis of Variance; Female; Humans; Lewy Body Disease; Male; Nerve Tissue Proteins; Peptide Fragments; Radioimmunoassay; tau Proteins
PY - 2009
Y1 - 2009
N2 - Dementia with Lewy bodies (DLB) is the second most common form of neurodegenerative dementia after Alzheimer's disease (AD). The underlying neurobiological mechanism of DLB is not fully understood and no generally accepted biomarkers are yet available for the diagnosis of DLB. In a recent MRI study, DLB patients displayed hypothalamic atrophy whereas this region was not affected in AD patients. Cocaine and amphetamine regulated transcript (CART) is a neuropeptide expressed selectively in neurons in the hypothalamus. Here, we found that CSF CART levels were significantly reduced by 30% in DLB patients (n = 12) compared to controls (n = 12) as well as to AD patients (n = 14) using radioimmunoassay. Our preliminary results suggest that reduced CSF CART is a sign of hypothalamic dysfunction in DLB and that it may serve as a biomarker for this patient group.
AB - Dementia with Lewy bodies (DLB) is the second most common form of neurodegenerative dementia after Alzheimer's disease (AD). The underlying neurobiological mechanism of DLB is not fully understood and no generally accepted biomarkers are yet available for the diagnosis of DLB. In a recent MRI study, DLB patients displayed hypothalamic atrophy whereas this region was not affected in AD patients. Cocaine and amphetamine regulated transcript (CART) is a neuropeptide expressed selectively in neurons in the hypothalamus. Here, we found that CSF CART levels were significantly reduced by 30% in DLB patients (n = 12) compared to controls (n = 12) as well as to AD patients (n = 14) using radioimmunoassay. Our preliminary results suggest that reduced CSF CART is a sign of hypothalamic dysfunction in DLB and that it may serve as a biomarker for this patient group.
U2 - 10.1016/j.neulet.2009.02.008
DO - 10.1016/j.neulet.2009.02.008
M3 - Journal article
C2 - 19356602
VL - 453
SP - 104
EP - 106
JO - Neuroscience letters. Supplement
JF - Neuroscience letters. Supplement
SN - 0167-6253
IS - 2
ER -
ID: 19978200